Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  3D printed personalised long-acting implants for effective cancer treatment

   School of Pharmacy

This project is no longer listed on and may not be available.

Click here to search for PhD studentship opportunities
  Prof Dimitrios Lamprou  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

According to WHO, cancer is the second leading cause of death worldwide, with nearly 1 in 6 deaths been due to cancer. The principal modes of cancer management are surgery, radiotherapy, chemotherapy and pharmaceutical agents. However, there are many side effects from extant treatments e.g., invasiveness of surgery, and with other treatments being systemic in nature; therefore, only a small fraction of the drugs reaches the tumour site. Due to the short period of actions, repeated doses are often required, which can lead to exacerbation of side effects and inconvenience. Due to these obstacles, targeted or localised release technology coupled with long-acting treatment functionality is a key research theme to replace systemic administration therapies and show potential for advancing cancer treatment including capability of personalizing the treatment. One especially promising therapeutic option gaining prominence is the use of multifunctional implants combining tumour-killing ability while promoting bone resorption/growth. Therefore, the main goal of this project is to investigate new approaches for targeted long-acting drug release for effective cancer therapies based on 3D printed drug-loaded implants.

Biological Sciences (4) Engineering (12) Medicine (26)
Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.

 About the Project